Legal Opinion
In Re Lupron® Marketing & Sales Practices Litigation
District Court, D. Massachusetts
Decided November 25, 2003No. MDL.1430, 01-CV-10861-RGSPublishedCited by 71 opinions
1Opinion of the Court
MEMORANDUM AND ORDER ON DEFENDANTS’ MOTION TO DISMISS CORRECTED CONSOLIDATED AMENDED CLASS ACTION COMPLAINT AND SECOND AMENDED CONSOLIDATED COMPLAINT 1
STEARNS, District Judge.
Plaintiffs, who are cancer patients and health care plans, accuse defendants Abbott Laboratories (Abbott), Takeda Chemical Industries, Ltd. (Takeda), and TAP Pharmaceutical Products, Inc. (TAP) of conspiring to artificially inflate the price of the drug Lupron® in violation of the civil provisions of the Racketeer Influenced and Corrupt Organizations Act (RICO), 18 U.S.C. § 1962. 2 The class action plaintiffs consist of…
2Cases cited108 opinions
- Kotteakos v. United StatesSupreme Court of the United States · 1946
- Baker v. CarrSupreme Court of the United States · 1962
- Neder v. United StatesSupreme Court of the United States · 1999
- Sedima, S. P. R. L. v. Imrex Co.Supreme Court of the United States · 1985
- H. J. Inc. v. Northwestern Bell Telephone Co.Supreme Court of the United States · 1989
103 more not listed; retrieve them via the Exa API.
3Cited by71 opinions
- Deveny v. ENTROPIN, INC.California Court of Appeal · 2006
- In Re Pharmaceutical Industry Average Wholesale Price LitigationDistrict Court, D. Massachusetts · 2007
- In re Lupron Marketing & Sales Practices LitigationDistrict Court, D. Massachusetts · 2005
- Massachusetts v. Mylan LaboratoriesDistrict Court, D. Massachusetts · 2005
- Shaulis v. Nordstrom Inc.District Court, D. Massachusetts · 2015
66 more not listed; retrieve them via the Exa API.